PH31319A - Method for treatment of autoimmune hepatitis. - Google Patents

Method for treatment of autoimmune hepatitis.

Info

Publication number
PH31319A
PH31319A PH49229A PH49229A PH31319A PH 31319 A PH31319 A PH 31319A PH 49229 A PH49229 A PH 49229A PH 49229 A PH49229 A PH 49229A PH 31319 A PH31319 A PH 31319A
Authority
PH
Philippines
Prior art keywords
autoimmune hepatitis
treatment
amount
corticosteroid
alpha
Prior art date
Application number
PH49229A
Other languages
English (en)
Inventor
Paul B Chretien
Milton G Mutchmick
Original Assignee
Alpha 1 Biomedicals
Governors Of Wayne Board Of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals, Governors Of Wayne Board Of filed Critical Alpha 1 Biomedicals
Publication of PH31319A publication Critical patent/PH31319A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH49229A 1993-10-26 1994-10-24 Method for treatment of autoimmune hepatitis. PH31319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/141,013 US5468729A (en) 1993-10-26 1993-10-26 Method for treatment of autoimmune hepatitis

Publications (1)

Publication Number Publication Date
PH31319A true PH31319A (en) 1998-07-06

Family

ID=22493765

Family Applications (1)

Application Number Title Priority Date Filing Date
PH49229A PH31319A (en) 1993-10-26 1994-10-24 Method for treatment of autoimmune hepatitis.

Country Status (8)

Country Link
US (1) US5468729A (OSRAM)
AU (1) AU8086894A (OSRAM)
MY (1) MY115157A (OSRAM)
PH (1) PH31319A (OSRAM)
SG (1) SG46620A1 (OSRAM)
TW (1) TW249754B (OSRAM)
WO (1) WO1995011696A1 (OSRAM)
ZA (1) ZA948252B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806632D0 (en) * 1998-03-28 1998-05-27 Stevenson Robert Peptide factor
NZ532310A (en) * 2001-10-05 2007-02-23 Combinatorx Inc Combinations comprising a tetra-substituted pyrimidopyrimidine and a corticosteroid for the treatment of immunoinflammatory disorders
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007139753A2 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
ITRM20060584A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 la preparazione di un medicamento per la prevenzione e la cura delle malattie autoimmuni
EP2427213B1 (en) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
KR102536881B1 (ko) 2011-04-29 2023-05-26 셀렉타 바이오사이언시즈, 인크. 항원-특이적 이펙터 ｔ 세포의 결실을 위한 관용원성 합성 나노운반체
MX380164B (es) 2013-05-03 2025-03-12 Selecta Biosciences Inc Uso de una macromolécula terapéutica y una composición que comprende nanoportadores sintéticos que se unen a inmunosupresores para reducir la hipersensibilidad tipo i y tipo iv en un sujeto.
CN106715699A (zh) 2014-09-07 2017-05-24 西莱克塔生物科技公司 用于减弱抗病毒转移载体免疫应答的方法和组合物
ES3036482T3 (en) 2017-03-11 2025-09-19 Cartesian Therapeutics Inc Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
TW224053B (OSRAM) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
MY115157A (en) 2003-04-30
AU8086894A (en) 1995-05-22
TW249754B (OSRAM) 1995-06-21
MX9408106A (es) 1997-09-30
ZA948252B (en) 1996-04-22
SG46620A1 (en) 1998-02-20
US5468729A (en) 1995-11-21
WO1995011696A1 (en) 1995-05-04

Similar Documents

Publication Publication Date Title
US5037384B2 (en) Method and apparatus for the treatment of complicated retinal detachments
PL299163A1 (en) Method of conducting lepaeoscopic operations in particular those of hernia and leparoscopic apparatus therefor
AU7930291A (en) Method and apparatus for dental treatment
HU9400758D0 (en) Composition and method of treating hepatitis c
PH31319A (en) Method for treatment of autoimmune hepatitis.
EP0420871A4 (en) Method and compositions for treatment of parkinsonism syndrome in mammals
GB9014307D0 (en) Method of treatment and compositions therefor
ZA931778B (en) Method and composition for the treatment of osteoporosis
AU1193995A (en) An apparatus and method of waste treatment
ZA935055B (en) Composition and method of treating hepatitis b
GB2261832B (en) Method of treating waste and apparatus for use in the method
AU7123498A (en) Dynamic table/shield apparatus and method of using same in moving-table total body irradiation treatment
EP0253702A3 (en) Method and apparatus for the treatment of waste in an apparatus for accelerated fermentation
GB9010058D0 (en) Method and composition for the treatment of cancer
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU1414995A (en) Residue and waste treatment process
AU1364892A (en) Method and apparatus for control of addition of modifying agent for in place treatment
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
GB2299271B (en) An apparatus and method of waste treatment
CA2188871A1 (en) Method for Treating Psoriasis
ZA914464B (en) Method and compositions for treating hiv-type 1 infection
GB9223836D0 (en) Method of controlling an electron beam in an electron accelerator and an electron accelerator
GEP19950240B (en) Method for the Recovery of Harmonious Bioenergetic and Psychoemotional Balance in Human Body
AU637568B3 (en) Method and composition for treatment of metals
ZA937005B (en) Compositions and methods for waste treatment